These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24054000)

  • 1. Differential brain and spinal cord cytokine and BDNF levels in experimental autoimmune encephalomyelitis are modulated by prior and regular exercise.
    Bernardes D; Oliveira-Lima OC; Silva TV; Faraco CC; Leite HR; Juliano MA; Santos DM; Bethea JR; Brambilla R; Orian JM; Arantes RM; Carvalho-Tavares J
    J Neuroimmunol; 2013 Nov; 264(1-2):24-34. PubMed ID: 24054000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic exercise confers neuroprotection in experimental autoimmune encephalomyelitis.
    Pryor WM; Freeman KG; Larson RD; Edwards GL; White LJ
    J Neurosci Res; 2015 May; 93(5):697-706. PubMed ID: 25510644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total glucosides of peony attenuates experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Huang Q; Ma X; Zhu DL; Chen L; Jiang Y; Zhou L; Cen L; Pi R; Chen X
    J Neuroimmunol; 2015 Jul; 284():67-73. PubMed ID: 26025060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
    Olechowski CJ; Tenorio G; Sauve Y; Kerr BJ
    Exp Neurol; 2013 Mar; 241():113-21. PubMed ID: 23291347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
    Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
    Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing the BDNF and NGF loss involved in the effects of cornel iridoid glycoside on attenuation of experimental autoimmune encephalomyelitis in mice.
    Qu Z; Zheng N; Zhang Y; Zhang L; Liu J; Wang Q; Yin L
    Neurol Res; 2016 Sep; 38(9):831-7. PubMed ID: 27373350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse.
    Hidaka Y; Inaba Y; Matsuda K; Itoh M; Kaneyama T; Nakazawa Y; Koh CS; Ichikawa M
    J Neurol Sci; 2014 May; 340(1-2):117-22. PubMed ID: 24655735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of exercise in a relapsing-remitting model of experimental autoimmune encephalomyelitis.
    Klaren RE; Stasula U; Steelman AJ; Hernandez J; Pence BD; Woods JA; Motl RW
    J Neurosci Res; 2016 Oct; 94(10):907-14. PubMed ID: 27312674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
    Benson CA; Wong G; Tenorio G; Baker GB; Kerr BJ
    Behav Brain Res; 2013 Sep; 252():302-11. PubMed ID: 23777648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-BFI ameliorates EAE-induced mouse spinal cord damage: effective therapeutic time window and possible mechanisms.
    Li F; Zhang ZX; Liu YF; Xu HQ; Hou ST; Zheng RY
    Brain Res; 2012 Nov; 1483():13-9. PubMed ID: 22985669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Zhu D; Liu M; Yang Y; Ma L; Jiang Y; Zhou L; Huang Q; Pi R; Chen X
    J Neurosci Res; 2014 Sep; 92(9):1217-26. PubMed ID: 24798871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis.
    Yao SQ; Li ZZ; Huang QY; Li F; Wang ZW; Augusto E; He JC; Wang XT; Chen JF; Zheng RY
    J Neurochem; 2012 Oct; 123(1):100-12. PubMed ID: 22639925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The blood-brain barrier-permeable catechol-O-methyltransferase inhibitor dinitrocatechol suppresses experimental autoimmune encephalomyelitis.
    Polak PE; Lin SX; Pelligrino D; Feinstein DL
    J Neuroimmunol; 2014 Nov; 276(1-2):135-41. PubMed ID: 25242632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An electrophysiologic approach to quantify impaired synaptic transmission and plasticity in experimental autoimmune encephalomyelitis.
    Prochnow N; Gold R; Haghikia A
    J Neuroimmunol; 2013 Nov; 264(1-2):48-53. PubMed ID: 24090654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1 overexpression exacerbate experimental allergic encephalomyelitis.
    Guo Y; Chung SK; Siu CW; Kwan SC; Ho PW; Yeung PK; Chan KH
    J Neuroimmunol; 2014 Nov; 276(1-2):64-70. PubMed ID: 25205217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation.
    Zarruk JG; Berard JL; Passos dos Santos R; Kroner A; Lee J; Arosio P; David S
    Neurobiol Dis; 2015 Sep; 81():93-107. PubMed ID: 25724358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGB1 expression patterns during the progression of experimental autoimmune encephalomyelitis.
    Sun Y; Chen H; Dai J; Zou H; Gao M; Wu H; Ming B; Lai L; Xiao Y; Xiong P; Xu Y; Gong F; Zheng F
    J Neuroimmunol; 2015 Mar; 280():29-35. PubMed ID: 25773152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prior regular exercise improves clinical outcome and reduces demyelination and axonal injury in experimental autoimmune encephalomyelitis.
    Bernardes D; Brambilla R; Bracchi-Ricard V; Karmally S; Dellarole A; Carvalho-Tavares J; Bethea JR
    J Neurochem; 2016 Jan; 136 Suppl 1():63-73. PubMed ID: 26364732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation.
    Quast I; Keller CW; Weber P; Schneider C; von Gunten S; Lünemann JD
    J Neuroinflammation; 2016 Feb; 13():42. PubMed ID: 26893156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of the selective progesterone receptor agonist Nestorone for chronic experimental autoimmune encephalomyelitis.
    Garay L; Gonzalez Deniselle MC; Sitruk-Ware R; Guennoun R; Schumacher M; De Nicola AF
    J Neuroimmunol; 2014 Nov; 276(1-2):89-97. PubMed ID: 25200475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.